麗珠醫藥集團股份有限公司 Livzon Pharmaceutical Group Inc. (stock code: 1513) has confirmed that its 2025 first extraordinary general meeting (EGM) is scheduled for 2:00 p.m. on Wednesday, December 10, 2025. The meeting will take place in the Conference Room on the 6th Floor of the Headquarters Building at 38 Chuangye North Road, Jinwan District, Zhuhai, Guangdong Province, China.

The EGM will consider a series of special resolutions, including a proposal related to the cancellation of the Supervisory Committee and amendments to the Articles of Association. Additional proposals involve updates to the Rules and Procedures for General Meetings—along with a proposed renaming—and revisions to the Rules and Procedures for Board Meetings. An ordinary resolution covers proposed amendments to the Administrative Measures for the Use of Raised Funds. Another ordinary resolution will address the appointment of Ms. Wang Zhiyao as an independent non-executive Director for the company’s eleventh session of the Board.

According to the announcement, shareholders may attend the meeting in person or appoint proxies to act and vote on their behalf. Proxy forms must be delivered to the requisite address at least 24 hours before the meeting commences. Shareholders who submit proxy forms retain the right to attend and vote in person. The filing also includes a statement emphasizing that the collection and use of personal data provided by shareholders or proxies is intended solely for processing the relevant meeting procedures.